Proteins are very important molecules as therapeutics. They have several advantages over small molecule drugs but their use is limited by their circulation short half life, immunogenicity and physicochemical instability. Several approaches have been developed to improve the pharmacokinetics of proteins. One that is clinically proven is the covalent conjugation of poly ethylene glycol (PEG) to the protein. This is known as PEGylation. Problems associated with PEGylation include product heterogenicity and low conjugation efficiency. A new approach is applied in this study which is site-specific PEGylation and it is called disulfide bridging PEGylation.
INTRODUCTION
Proteins are very complex molecules. They have many key roles in regulating the biological functions inside the human body [1] . Therapeutic proteins are used for replacement therapies when specific endogenous protein is deficient [2] . There are some obstacles in the development of proteins as medicines, such as short half life, route of administration, high molecular weight, low solubility, low stability, hydrophilicity, purification and immunogenicity and this leads to poor pharmacokinetic properties [3] [4] [5] . To overcome these difficulties in the development of proteins as medicines (mainly their short half life) and to optimise their pharmacokinetic properties, several approaches have been developed such as, PEGylation, FC fusion, slow release formulations, protease-resistant variants, protein fusion and protein cross linking [6] [7] [8] [9] [10] [11] [12] .
PEGylation is the covalent attachment of polyethylene glycol (PEG) to the protein molecule. PEGylation is introduced to increase the half life of proteins. PEG is a neutral, hydrophilic, polymeric molecule that is considered non immunogenic and non toxic [9] . PEGylation is conducted by nucleophilic addition of electrophilic PEG reagents. PEG is unreactive by itself so must be modified so that it can be conjugated to a protein [13] [14] [15] [16] . These active groups on PEG can react with amino groups (alpha or epsilon) of lysine of the protein (lysine accounts for 10% of amino acids in a typical protein) [4, 9] . Due to the presence of different lysines in the protein molecule, multiple PEG molecules may attach to a single protein causing heterogeneity and positional isomerism. Each positional isomer has different activity and may lead to batch to batch variability. Site specific PEGylation has been introduced to overcome these problems. One of the methods utilized for site specific PEGylation is Disulfide Bridging PEGylation. This technique involves 2 steps, first; reduction of disulfide bond to release its two thiols, and second; using bis-alkylating PEG reagent to rebridge the released free thiols [17, 18] . This technique requires the reduction of native disulfides which required (in proteins other than transferrin) unfolding for proteins with multiple disulfides which leads to loos their activities. Therefore controlled reduction of proteins is required to avoid unfolding and to avoid losing their activities [19] [20] [21] .
Transferrin (Tf) is a glycoprotein that is widely distributed in the blood. Tf has 19 disulfide bonds and some of them are close to the surface [15] , which makes them ideal to investigate the possibility of control reduction of disulfide bonds.
Investigating the possibility of reduction of Tf using mild conditions may help in developing the PEGylation of Tf. Our aim in this research is to investigate the possibility of controlled reduction of Tf using mild conditions and by controlling the number of disulfide bonds that are opened we can control the PEGylation process to achieve a higher amount of site-specific mono-PEGylation and minimise heterogeinicity and positional isomerism and this may contribute to the development of proteins with improved solubility and pharmacokinetic properties to be presented as medicin.
MATERIALS AND METHODS

Materials
Human apo-transferrin, human holo-transferrin (MW 76-81 KDa) and DLdithiothreitol (DTT) were purchased from sigma Aldrich. Novex Bis-tris 4-12% precast gels, SDS-PAGE kit, Ellman's reagent (5,5-dithiobis(2-nitrobenzoic acid)). 
Methods
Reduction of disulfide bonds using DTT( DL-Dithiothreitol)
Reduction of Tf was conducted with DTT at different concentrations. Tf was prepared as a solution of (1.0 mg/ml) in sodium phosphate buffer (0. 
Quantification of free thiols using Ellman's assay
To calculate the amount of free thiols /protein the Ellman's test was used. We The solutions were allowed to incubate for 15 minutes at 20 0 C. Using plastic cuvettes, the absorbance was measured at 412 nm using a UV spectrometer. The molar concentration of thiols in the sample was then calculated by dividing the absorbance measured by the molar extinction coefficient of thiols which is 14150 M -1 cm -1 [22] . The value obtained was divided by the molar concentration of the protein in the sample to obtain the number of thiols/protein.
PEGylation of protein using bis-sulfone PEG 2
The reduced protein solution was taken and the molar concentration of the protein in the sample was calculated. The amount of bis-sulfone PEG 2 that was needed was calculated by multiplying the molar concentration of the protein in the gel was then removed and rinsed several times with water then scanned [18] .
Barium iodide staining of gels
Barium iodide staining was used to detect PEG in the SDS-PAGE gel. In the case of a PEGylated protein the procedure was to first use cromassi blue to dye the protein as prescribed above followed by barium iodide staining to dye PEG. In the beginning the gel left in water overnight to remove excess cromassi blue stain then the gel was placed in (40.0 ml) of (0.1 M) perchloric acid for 10 minutes. Then (10.0 ml) of 5 % barium chloride solution was added to the gel and left for 10 minutes.
After 10 minutes (2.0 ml) of (0.1 M) iodine was added to the gel and left for another 10 minutes. The gel was then removed and rinsed with water several times and left in water for 3-5 minutes to remove the excess iodine. The non-PEGylated protein remains blue while the PEGylated one becomes brown in color then scanned [18] . 
SEC-HPLC
RESULTS AND DISCUSSION
Transferrin Tf is an extracellular protein with 19 disulfides some of them are accessible which makes it an ideal molecule to investigate the possibility of partial reduction and PEGylation. Tf binds iron in the blood and transports it throughout the body. Tf receptors are widely distributed inside the human body and overexpressed in tumor cells which make Tf an ideal molecule to investigate targeting delivery system [23, 24] . We hypothesized that Tf bound to iron might be more tightly folded and might display a different disulfide reduction product therefore both forms of Tf were examined which are apo-Tf (iron free Tf) and holo-Tf (iron loaded Tf), for the investigation of possible reduction of the lowest number of disulfide bonds followed by bis-alkylation PEGylation.
The reduction of holo-Tf was examined because it is the iron loaded form and it binds with the receptor in this form, using DTT as the reducing agent as explained in the experimental part. After reduction had been carried out the Ellman's test was conducted to quantify the number of thiols in the sample. The number of thiols/protein calculated was (12.93 thiols/protein) which suggest that 6 disulfide bonds had been reduced out of the 19 disulfide bonds in holo-Tf. To optimize the reaction conditions to achieve partial reduction we continued the reduction of holo-Tf with the same conditions using different molar concentrations of DTT (50, 30, 10, 1 mM). The result can be observed in (Table 1) . We observed a reduction in the number of disulfide bonds reduced parallel to the reduction in concentration of DTT. As we increase the molar concentration of DTT, more DTT molecules will target the deeper bonds together with the surface bonds. This will reduce large number of disulfide bonds in Tf. We concluded from the results above that the best concentration of DTT solution to be used to achieve partial reduction is (1.0) mM.
To confirm the number of disulfide bonds reduced as calculated according to We reduced apo-Tf using the same conditions that were used for reduction of holo-Tf and PEGylated with 30 KDa and 10 KDa bis-sulfone PEG 2 to see if there is a difference between the two forms of Tf and the results observed in Figure 3 (C and D). There is no observed difference in the results between holo and apo-Tf which confirms that iron has no effect on reduction and PEGylation.
To eliminate the possibility of other reactions in the sample during PEGylation, a control reaction was conducted where bis-sulfone PEG KDa 30 was added to both types of Tf without reduction incubated overnight in the refrigerator (4 0 C). SDS-PAGE of the control reaction shows an unexpected band similar in position to monoPEGylation. This suggests that an interaction between bis-sulfone PEG 2 and holo-Tf and apo-Tf takes place as shown in Figure 4 .
All the above results indicate that it is possible to control the reduction of multiple disulfide bonds in transferrin. We were able to reduce only two disulfides (with predominant monoreduction) with mild conditions, which is 0.5 mM DTT without the need of adding a denaturant. Also we conclude that iron has no effect or interference with either reduction or PEGylation of Tf. Using higher equivalent of PEG for PEGylation is unnecessary, and using the equivalents of 1:2 (protein:PEG)
gives satisfactory mono-PEGylation.
SEC-HPLC
To confirm our PEGylation SEC-HPLC is used for separation of the sample components according to size. Using SEC gives an idea about the different compositions of the sample. We chose 3 samples to run on SEC. For each sample tested on SEC, samples from the peaks were collected and tested on SDS-PAGE. The first sample run on SDS-PAGE was the native holo-Tf. We run the native protein to confirm the time at which the peak for Tf appears, and to see if there is any contamination or aggregation in the sample. Figure 5 shows the peak for apo-Tf after 80 minutes.
The second sample to run on SEC was the holo-Tf reduced with 0.5 mM DTT and PEGylated with 2 equivalent 30 KDa PEG as shown in Figure 6 . There are peaks at 55, 60 and 80 minutes. From the previous experiment we know that the peak for native holo-Tf appears at 80 minutes, so we suggested that the peak at 55 minutes is for di-PEGylation and at 60 minutes mono-PEGylation because in SEC larger molecules appear first. Samples collected at the peaks tested on SDS-PAGE and the results confirm our suggestion. effect on reduction or PEGylation reaction of Tf. From the results observed in our experiments we concluded that it is possible to control the reduction conditions to achieve partial reduction in multiple disulfide proteins that have solvent accessible disulfide bonds and this give promising way to prepare reduced protein that may have better stability and solubility and improved pharmacokinetic properties to be used as medicines. 
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